The National Institute for Health and Care Excellence (NICE) has approved a chimeric antigen receptor (CAR) T-cell therapy for adults with large B-cell lymphoma. The treatment significantly delays ...

Lymphoma is a type of cancer that begins in lymphocytes — the white blood cells that play a vital role in the immune system. These cells are located in areas such as the lymph nodes, spleen, thymus, ...

A simultaneous or sequential combination of brentuximab vedotin and radiotherapy is feasible and well tolerated in patients ...

Hodgkin lymphoma and other malignancies that express the CD30 protein have been the scourge of oncologists for decades. For ...

Learn the signs, symptoms, risk factors, and treatments for Hodgkin lymphoma—plus insights from a doctor who’s also a ...

To the Editor: Svoboda et al. (May 8 issue) 1 report on a study of an enhanced chimeric antigen receptor (CAR) T-cell product (huCART19-IL18) in patients with relapsed or refractory lymphoma after ...

An innovative approach could transform the treatment landscape for DLBCL patients, offering hope to those who might otherwise ...

New research challenges the status quo that cancer treatments are responsible for accelerating the aging process, indicating that cancer itself also plays a role. A team of researchers from Moffitt ...

Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors This knowledge can be used to ...